Top Markets
Coin of the day
CNS Pharmaceuticals, Inc. CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals, Inc.

CNSP
Classement en actions #33273
CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily... CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily focused on developing innovative anti-cancer therapies for tumors affecting the brain and central nervous system. Its primary investigational compound, Berubicin, an anthracycline, is currently progressing through Phase I and II clinical trials as a potential treatment for glioblastoma multiforme, an aggressive form of brain cancer. To bolster its research and development initiatives, the company has entered into several strategic agreements. These include licensing arrangements with Houston Pharmaceuticals, Inc., The University of Texas M.D. Anderson Cancer Center, and Animal Life Sciences, LLC. Additionally, CNS Pharmaceuticals has a development agreement in place with WPD Pharmaceuticals Inc. and a collaborative partnership with Reata Pharmaceuticals, Inc. The company was founded in 2017 and is headquartered in Houston, Texas.
Prix de l'action
$5.47
Dernière synchronisation: 2026-08-14
Capitalisation boursière
$7.99M
Changement (1 jour)
6.21%
Changement (1 an)
7.47%
Pays
US
Échange CNS Pharmaceuticals, Inc. (CNSP)

Catégorie

Historique des divisions d’actions pour CNS Pharmaceuticals, Inc. (CNSP)
L’action CNS Pharmaceuticals, Inc. (symbole : CNSP) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 17, 2026.
Une action CNSP achetée avant le Aug 17, 2026 équivaudrait aujourd’hui à 0 actions CNSP.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE